In conclusion, the simultaneous evaluation of non-invasive SWE and CPI suggests the feasibility for estimating the personalized need for insulin initiation in patients with T2DM, integrating both biophysical and hormonal perspectives. The gene discussed is INS; the disease is type 2 diabetes mellitus.